SCHD Yahoo Finance historical charts reveal resilience during recent market drawdowns, reflecting broad exposure to large-cap stocks with strong cash flow fundamentals. Despite the loss of patent protection on its No. 1 arthritis therapy Humira, AbbVie hasn’t been affected as badly as many feared. While sales are down year over year, the drug is still reporting billions of dollars in sales. Coupled with multi-billion dollar sales from other drugs in its portfolio, AbbVie hasn’t missed a step. SCHD seeks to match the performance of the Dow Jones U.S. Dividend 100 Index before fees and expenses. The Dow Jones U.S. Dividend 100 Index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. Historical volatility metrics from SCHD Yahoo Finance show a beta close to 0.88, underscoring its lower risk profile compared to the S&P
